PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Clinical trials for PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME trials appear
Sign up with your email to follow new studies for PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could immune therapy calm sudden OCD and food refusal in kids?
Disease control CompletedThis study tested a monthly infusion of donated antibodies (IVIG) for 6 months in 17 children aged 4-17 with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), a condition causing sudden severe OCD, anxiety, or food refusal. The goal was to see if the treatment is safe and c…
Matched conditions: PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Phase: PHASE2 • Sponsor: Göteborg University • Aim: Disease control
Last updated May 26, 2026 07:06 UTC
-
New study reveals hidden costs of treating PANS with IVIG
Knowledge-focused CompletedThis study surveyed 65 families to understand the economic and quality-of-life impact of IVIG treatment for children with PANS or PANDAS. Researchers asked about medical visits, insurance coverage, work and school attendance, and emotional well-being. The goal is to better descri…
Matched conditions: PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated May 26, 2026 07:14 UTC